This case report also reinforces the importance of ensuring that appropriate hematological information is obtained early and that thrombophilia screening, including testing for JAK2 mutation, is performed whenever a patient presents with benign PVT and a healthy liver. Here, JAK2 is linked to Rare hereditary thrombophilia.